These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

672 related articles for article (PubMed ID: 23012466)

  • 1. Incremental diagnostic value of SPECT/CT with 131I scintigraphy after radioiodine therapy in patients with well-differentiated thyroid carcinoma.
    Maruoka Y; Abe K; Baba S; Isoda T; Sawamoto H; Tanabe Y; Sasaki M; Honda H
    Radiology; 2012 Dec; 265(3):902-9. PubMed ID: 23012466
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differentiated thyroid carcinoma: Incremental diagnostic value of
    Zilioli V; Peli A; Panarotto MB; Magri G; Alkraisheh A; Wiefels C; Rodella C; Giubbini R
    Endocrine; 2017 Jun; 56(3):551-559. PubMed ID: 27709475
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High Level of Agreement Between Pretherapeutic 124I PET and Intratherapeutic 131I Imaging in Detecting Iodine-Positive Thyroid Cancer Metastases.
    Ruhlmann M; Jentzen W; Ruhlmann V; Pettinato C; Rossi G; Binse I; Bockisch A; Rosenbaum-Krumme S
    J Nucl Med; 2016 Sep; 57(9):1339-42. PubMed ID: 27151981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical applications of single-photon emission computed tomography/computed tomography in post-ablation
    Jiang L; Xiang Y; Huang R; Tian R; Liu B
    Pediatr Radiol; 2021 Aug; 51(9):1724-1731. PubMed ID: 33759024
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Diagnosis of metastases from postoperative differentiated thyroid cancer: comparison between FDG and FLT PET/CT studies.
    Nakajo M; Nakajo M; Jinguji M; Tani A; Kajiya Y; Tanabe H; Fukukura Y; Nakabeppu Y; Koriyama C
    Radiology; 2013 Jun; 267(3):891-901. PubMed ID: 23468571
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of 131I-SPECT/CT images obtained with an integrated system in the follow-up of patients with thyroid carcinoma.
    Tharp K; Israel O; Hausmann J; Bettman L; Martin WH; Daitzchman M; Sandler MP; Delbeke D
    Eur J Nucl Med Mol Imaging; 2004 Oct; 31(10):1435-42. PubMed ID: 15221294
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of 131I SPECT/spiral CT on nodal staging of differentiated thyroid carcinoma at the first radioablation.
    Schmidt D; Szikszai A; Linke R; Bautz W; Kuwert T
    J Nucl Med; 2009 Jan; 50(1):18-23. PubMed ID: 19091884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MRI versus ¹³¹I whole-body scintigraphy for the detection of lymph node recurrences in differentiated thyroid carcinoma.
    Mihailovic J; Prvulovic M; Ivkovic M; Markoski B; Martinov D
    AJR Am J Roentgenol; 2010 Nov; 195(5):1197-203. PubMed ID: 20966328
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Staging of differentiated thyroid carcinoma using diagnostic 131I SPECT/CT.
    Wong KK; Sisson JC; Koral KF; Frey KA; Avram AM
    AJR Am J Roentgenol; 2010 Sep; 195(3):730-6. PubMed ID: 20729453
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 131I SPECT/CT in the follow-up of differentiated thyroid carcinoma: incremental value versus planar imaging.
    Spanu A; Solinas ME; Chessa F; Sanna D; Nuvoli S; Madeddu G
    J Nucl Med; 2009 Feb; 50(2):184-90. PubMed ID: 19164225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Five months' follow-up of patients with and without iodine-positive lymph node metastases of thyroid carcinoma as disclosed by (131)I-SPECT/CT at the first radioablation.
    Schmidt D; Linke R; Uder M; Kuwert T
    Eur J Nucl Med Mol Imaging; 2010 Apr; 37(4):699-705. PubMed ID: 19936746
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a
    Spanu A; Nuvoli S; Marongiu A; Gelo I; Mele L; Piras B; Madeddu G
    BMC Cancer; 2020 Mar; 20(1):239. PubMed ID: 32197595
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Detection of subcentimeter metastatic cervical lymph node by 18F-FDG PET/CT in patients with well-differentiated thyroid carcinoma and high serum thyroglobulin but negative 131I whole-body scan.
    Kunawudhi A; Pak-art R; Keelawat S; Tepmongkol S
    Clin Nucl Med; 2012 Jun; 37(6):561-7. PubMed ID: 22614187
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Can (18)F-FDG-PET/CT be generally recommended in patients with differentiated thyroid carcinoma and elevated thyroglobulin levels but negative I-131 whole body scan?
    Bannas P; Derlin T; Groth M; Apostolova I; Adam G; Mester J; Klutmann S
    Ann Nucl Med; 2012 Jan; 26(1):77-85. PubMed ID: 22006540
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Single photon emission computed tomography (SPECT)/computed tomography using Iodine-123 in patients with differentiated thyroid cancer: additional value over whole body planar imaging and SPECT.
    Barwick T; Murray I; Megadmi H; Drake WM; Plowman PN; Akker SA; Chew SL; Grossman AB; Avril N
    Eur J Endocrinol; 2010 Jun; 162(6):1131-9. PubMed ID: 20212015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incremental value of diagnostic 131I SPECT/CT fusion imaging in the evaluation of differentiated thyroid carcinoma.
    Wong KK; Zarzhevsky N; Cahill JM; Frey KA; Avram AM
    AJR Am J Roentgenol; 2008 Dec; 191(6):1785-94. PubMed ID: 19020251
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of the diagnostic and prognostic values of 99mTc-MDP-planar bone scintigraphy, 131I-SPECT/CT and 18F-FDG-PET/CT for the detection of bone metastases from differentiated thyroid cancer.
    Qiu ZL; Xue YL; Song HJ; Luo QY
    Nucl Med Commun; 2012 Dec; 33(12):1232-42. PubMed ID: 23111353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technetium-99m-pertechnetate whole-body SPET/CT scan in thyroidectomized differentiated thyroid cancer patients is a useful imaging modality in detecting remnant thyroid tissue, nodal and distant metastases before
    Lou K; Gu Y; Hu Y; Wang S; Shi H
    Hell J Nucl Med; 2018; 21(2):121-124. PubMed ID: 30089313
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Iodine-131 SPET/CT and 18F-FDG PET/CT for the identification and localization of mediastinal lymph node metastases from differentiated thyroid carcinoma.
    Xu YH; Shen CT; Xue YL; Qiu ZL; Luo QY
    Hell J Nucl Med; 2013; 16(3):199-203. PubMed ID: 24251307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. 131I SPECT/CT in the follow-up of patients with differentiated thyroid carcinoma.
    Menges M; Uder M; Kuwert T; Schmidt D
    Clin Nucl Med; 2012 Jun; 37(6):555-60. PubMed ID: 22614186
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 34.